Andrew Beaden
Analyst · Luke Folta of Jefferies
Thank you, Brian. And welcome, everyone, to the call. Brian covered the divisional sales announcements and my first slide, Slide 9, shows how that consolidates into the group revenue changes in Q4 and the full year. Total revenues for Q4 2013 was $160 million, with net revenue of $150 million. And the rare earth chemical surcharge was only $1 million. The group's underlying net revenue was down 9% or $11.4 million. Adjusting for FX translation, difference is of a positive $0.7 million, with both divisions having a weaker quarter due to the factors Brian outlined before.
For the full year, the revenue was therefore, $481.3 million, a fall from the $511.6 million last year, but this was mainly a result of the rare earth surcharge being reduced to customers by 31. -- $32.1 million after rare earth cost fell.
Translation differences were a negative $1.5 million for the year. And therefore, underlying trading revenue was up a small amount at $3.3 million.
Turning to the trading profit results on Slide 10. In Q4 2013, on the back of lower sales, trading profit was down at $15 million, when compared to $16.1 million for Q4, 2012. Elektron's profits was down from $11.8 million in Q4 2012 to $10.2 million in Q4 2013. The division's trading margin was only slightly down at 19.7% versus 19.9% last year.
Gas cylinders profit was up at $4.8 million compared to $4.3 million for Q4 2012, consistent with its improved performance in 2013. Trading profit margin was also improved at 7.5% versus 6.1% to Q4 2012. And therefore, the group's Q4 trading margin was 12.9%, higher than the 12.4% for Q4 2012.
Looking at the full-year performance, we have provided a series of bridges from 2012 to 2013 for each division and the group. These are Slides 11 to 13, and are designed to show the change in profits, as we would explain them in detail in the 20-F filing, which we made later this month.
Slide 11 shows the group's profit bridge, tracking the movement from $68.5 million in 2012 to $59.2 million for 2013. Looking at that slide, FX translation reduced profits by $0.4 million, the weaker trading predominantly in Europe and also U.S. defense markets reduced profits by $6.5 million, with the net changes in raw materials and sales prices having a group-wide net benefits of $0.4 million. FX transaction differences were negative $2.2 million. We have production efficiencies of a net benefit of $1.7 million. Share-based compensation charges from the IPO were $1.3 million and other cost increases were $1 million.
Slide 12 shows the same analysis for the Elektron division. You can see the key negative variance here is the weaker sales volume and associated mix of sales, which reduced profits by $10 million. There was also a margin impact due to changes in net selling prices when compared to the total out bridge fall in raw material costs, particularly in automotive sectors. And this did reduce profits by $2.7 million. There were some production inefficiencies too of $0.4 million, which we raised in earlier calls, due to lower utilization in the plants, again maybe in Europe. Electrons apportionment to the share-based compensation was $0.7 million. However, there were some significant cost savings achieved during the year of $2.9 million.
Slide 13 shows the same analysis but for the Gas Cylinders Division, the profit improvement being driven mainly by the improving trading variance of $6.6 million. This include
[Audio Gap]
I believe that we were cut off through our telecom's problem. And I think that's the point of the presentation that we were up to, which I believe was looking at the gas cylinders' profitability year-on-year, which would be Slide 13. Yes. Okay.
So this was the same analysis that we've seen for the other divisions. The profit improvement for gas cylinders being due to the improved trading variance of $6.6 million, which includes the benefits of the Dynetek acquisition, which added alternative fuel cylinder capacity for the year. Raw material costs were lower and we have some net sales price increases, which are also unofficial. Production efficiencies were achieved of $2.1 million, held by our automation projects. Employment and other costs were higher, up $3.9 million. But this includes investments in the alternative fuels and sales distribution areas along with costs in other areas such as research and developments, including the IOS medical oxygen delivery system.
Turning to the full income statement on Slide 14, for Q4, the total gross margins were higher at 25.9% for Q4 2013 versus 23.9% for Q4 2012. But with sales being low for the quarter, gross profit was down to $30 million versus $31.1 million. Administrative expenses are very similar at $13.2 million versus $13 million. We had a $1.8 million charge restructuring and similar costs, of which $1.7 million was a one-off actuarial charge in the USA relating to the take-up of a cash buyout or cash settlement offer to our deferred members of our U.S. defined benefit pension plan, which is already closed.
This being mainly funded by plan assets, this enables us to reduce the gross liabilities in the USA pension scheme by $11.7 million, which is part of a longer-term strategy to find ways to de-risk the pension liabilities across the whole group. This led to -- after this -- these costs, we have an operating profit of $13.2 million, with interest costs of $1.6 million and IAS 19 defined pension finance charges of $1.1 million, the profit before tax was $10.5 million. This compares to $10.7 million of Q4 2012. The final quarter tax charge was only 16%. This was the result of realizing the benefits of various tax-saving measures which I've spoken about before, but include the U.K. patent box credits, utilization of tax losses and optimizing state tax allocations in the U.S.A. I will cover this further in Slide 15 in a few moments.
At the bottom of Slide 14, you can see the EPS-to-ADS holders was $0.33 on unadjusted earnings, and $0.41 on adjusted net income. There is a non-GAAP reconciliation for adjusted net income in the slide appendices.
Looking at the full-year, the adjusted EBITDA is $76.6 million. Net income is $34.1 million and adjusted net income is $39.8 million. EPS per ADS for the full-year was $1.48 on the adjusted net income basis, and though not on the slide, the fully diluted figure is $1.42 per ADS. These figures were in fact higher than we have predicted at Q3, due to attaining the better-than-forecasted tax savings in Q4.
So turning to Slide 15. You can see 2 key things from the analysis of the group's performance by major trading regions: one, it was the U.K. operating businesses which suffered in 2013 when compared to 2012. But this was mainly a result of weaker sales and profits from exports into mainland Europe. Two, the change in the effective tax rates. The U.K. government did reduce its tax rate during 2013 and it's had a 1.25% impact on the effective U.K. rate, but with a much larger percentage of profits being made in higher tax jurisdictions. Like the USA, the tax saving measures, that we've talked about before, enabled us to avoid a potential charge as high as $14.7 million based on 2012 tax rates. So the $12.6 million 2013 charge represents $1.2 million -- I'm sorry, a $2.1 million tax saving. The effective group rate was 27%. Based on the same mix of profits, I am currently targeting around 28% effective rate for rate for 2014.
The next Slide, #16, shows the consolidated balance sheet. Overall, invested capital in the operating businesses was $227.1 million, net of pension deficits of $68 million as of the 31st of December, 2013. The point-in-time pension deficits fell by $29 million from $97 million at the end of 2012. This being due to better asset returns, slightly higher bond yields along with our own deficit repayments. The vast majority of the 2013 year-end deficit is in the U.K. defined benefit plan. Net assets or shareholders' equity of the group has risen to $191.7 million, up $42.9 million from the end of 2012. Net debt, debt minus cash is now $35.4 million.
Turning to cash flow in Slide 17, our operating cash flow for Q4 2013 was a positive $7.3 million. This was after paying $3.2 million of corporation tax, though we are now going to claim back $1.7 million in the first half of 2014, in relation to the various tax savings I mentioned before. Looking at investment cash flows, we made total investments of $13.3 million in Q4 2013, which included capital expenditure, our new plants [ph] and equipments of $10.1 million.
The largest single investment being in the expansion of our composite cylinder production facilities in Riverside, California, which has been operating at full capacity for the much of 2013. A further $2.3 million was in -- on intangible assets, the largest element being new ERP computer systems, which are SOX compliant and some development costs in relation to our major strategic growth initiatives, including CNG cylinders and related system technologies, chem cap products and Elektron 43 alloy technology for aircraft seating.
An additional $1 million was invested in the U.S. gas transportation module JV to fund that business going forward. Cash flow before financing was therefore, an outflow of $6 million. After paying dividends, net interest of $3.9 million, the net cash outflow was -- outflow of $9.9 million. For the full year, we generated operating cash flows after tax of $37.1 million versus $69 million for 2012. 2012 was significantly higher due to higher operating profits, but also a changing working capital. Working capital fell in 2012 due to the fall in rare earth costs and a reduction in our rare earth inventory levels. At the end of 2013, across the group, our inventory levels are higher due in part to the delay in the very large Australian gas transportation order, moving into 2014 and Elektron on the back of a stronger order book at the end of 2013 and the impact of the delayed shipments in Elektron's Zirconium operation, which Brian explained earlier.
The next slide shows return in invested capital, which was 24% in the quarter, compared to 31% for Q4 2012, lower because of the reduced profits. The full year was still a 22% return on invested capital.
My final slide relates to our banking facilities, which we have just agreed to extend out to April, 2019. As you can see, we have switched the agreement into U.S. dollars from pound sterling. The committed size has been increased from GBP 70 million to $150 million. We have added an uncommitted accordion of $50 million, which means the facility can be extended in the future to a $200 million facility. All the funds are available for acquisitions as well as organic growth funding. I'm pleased that we -- there was competition to join the extended facility and we have welcomed on board RBS and Santander, meaning that we have now have 5 major banks in the banking syndicate.
The interest rate margin is also reduced, the debt below 2x EBITDA by 0.25%, and there the facility is larger at $150 million. The non-utilization fees should be broadly the same in total when you compare them to the current smaller GBP 70 million facility. The facilities remain unsecured, through cross-guaranteed by all the U.K. and U.S. businesses. There was relaxation in the acquisition control levels before bank approvals are required, though we, of course, work closely with all our banks on any significant funding matters.
Thank you. I will now hand you back to Brian to sum up.